Tokyo, July 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062106) titled 'Establishment of novel cohort to define preclinical rheumatoid arthritis (TATEYAMA [Tracking Arthritis Through Early Yield And Monitoring in Advance] cohort study)' on July 1.
Study Type:
Observational
Primary Sponsor:
Institute - University of Toyama
Condition:
Condition - preclinical and very early rheumatoid arthritis.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Characterise preclinical/very early rheumatoid arthritis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inc...